GLP1R and endothelial dysfunction: Accumulating evidence suggests that GLP-1/GLP-1RAs increases the production of endothelial nitric oxide (NO) (106), reduces endothelial dysfunction (107), inflammation and oxidative stress (108) and also inhibits the transformation from monocytes to foam cells (109).